The number of ongoing prescription drug shortages rose slightly in the last quarter of 2025, but remained significantly lower ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Due to the “programmable” nature of the nanoparticle, researchers are able to “swap out the antibodies or the drugs to target different diseases — like autoimmune disorders or different types of ...

In the treatment of inflammatory bowel disease, synthetic mucus gels can be used to deliver monoclonal antibodies without inducing broad immunosuppression.

The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...

Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there's ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there's ...

Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...

More than 140 U.S. medical organizations are advocating for the passage of a bill that would increase NIH funding for fiscal ...

Novartis received breakthrough therapy designation from the FDA for ianalumab, a monoclonal antibody aimed at treating Sjögren’s disease. Ianalumab works by depleting B cells and blocking BAFF-R ...